SCHEMBL19081961

SCHEMBL19081961

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5ccc6sc7cc8oc9c%10ccccc%10ccc9c8cc7c6c5)cc4)c4ccccc34)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 14/20 0.41
CYP1B1 Q16678 14/20 0.41
CYP1A2 P05177 12/20 0.33
ABCB1 P08183 2/20 0.33
ABCC1 P33527 2/20 0.33
ABCG2 Q9UNQ0 2/20 0.33
PRKDC P78527 2/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
PSMD14 O00487 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
XDH P47989 1/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 1/20 0.33
PDE5A O76074 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081794 0.92 CYP1A1 (0.43) CYP1A1CYP1B1CYP1A2ABCB1ABCC1
SCHEMBL19080179 0.90 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2ABCB1ABCC1
SCHEMBL19081991 0.89 CYP1A1 (0.41) CYP1A1CYP1B1CYP1A2ABCB1ABCC1
SCHEMBL19081820 0.89 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2ABCB1ABCC1
SCHEMBL19109038 0.86 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2CYP2C9CYP2C19
SCHEMBL19080198 0.86 CYP1A1 (0.34) CYP1A1CYP1B1CYP1A2ABCB1ABCC1
SCHEMBL19081922 0.86 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2ABCB1ABCC1
SCHEMBL17944805 0.85 SMN1; SMN2 (0.35) CYP1A1CYP1B1CYP1A2PRKDCALDH1A1
SCHEMBL18268532 0.85 CASP3 (0.33) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1
SCHEMBL17945388 0.85 CASP3 (0.33) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.